You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 13, Issue 19

October-1 2021 - 300 articles

Cover Story: Magnetic resonance fingerprinting (MRF) is a relatively new framework for generating multiple quantitative magnetic resonance maps in a time-efficient manner. This review summarizes published studies on the detection and characterization of tumors using MRF. It also explores the use of MRF for radiotherapy planning. Currently, MRF still faces limitations such as limited motion robustness and prolonged post-processing time. However, with advances in technology, some of these limitations might be resolved through integration with deep learning and other novel AI techniques. The purpose of this review is to present the huge potential of MRF with a focus on oncological applications and make researchers in this area aware that this field is suitable for further studies. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (300)

  • Article
  • Open Access
5 Citations
3,272 Views
18 Pages

Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)

  • Kathrin D. Wurster,
  • Mariantonia Costanza,
  • Stephan Kreher,
  • Selina Glaser,
  • Björn Lamprecht,
  • Nikolai Schleussner,
  • Ioannis Anagnostopoulos,
  • Michael Hummel,
  • Korinna Jöhrens and
  • Harald Stein
  • + 9 authors

7 October 2021

In 50–60% of cases, systemic anaplastic large cell lymphoma (ALCL) is characterized by the t(2;5)(p23;q35) or one of its variants, considered to be causative for anaplastic lymphoma kinase (ALK)-positive (ALK+) ALCL. Key pathogenic events in ALK-nega...

  • Article
  • Open Access
17 Citations
4,604 Views
18 Pages

EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)

  • Simon Leonhard April-Monn,
  • Valentina Andreasi,
  • Marco Schiavo Lena,
  • Martin Carl Sadowski,
  • Corina Kim-Fuchs,
  • Michelle Claudine Buri,
  • Avanee Ketkar,
  • Renaud Maire,
  • Annunziata Di Domenico and
  • Jörg Schrader
  • + 6 authors

7 October 2021

Pancreatic neuroendocrine neoplasms are epigenetically driven tumors, but therapies against underlying epigenetic drivers are currently not available in the clinical practice. We aimed to investigate EZH2 (Enhancer of Zest homolog) expression in PanN...

  • Article
  • Open Access
14 Citations
2,984 Views
16 Pages

Reversal of Bortezomib-Induced Neurotoxicity by Suvecaltamide, a Selective T-Type Ca-Channel Modulator, in Preclinical Models

  • Cristina Meregalli,
  • Yuri Maricich,
  • Guido Cavaletti,
  • Annalisa Canta,
  • Valentina A. Carozzi,
  • Alessia Chiorazzi,
  • Evan Newbold,
  • Paola Marmiroli,
  • Cecilia Ceresa and
  • Arthur Diani
  • + 2 authors

7 October 2021

This study evaluated suvecaltamide, a selective T-type calcium channel modulator, on chemotherapy-induced peripheral neurotoxicity (CIPN) and anti-cancer activity associated with bortezomib (BTZ). Rats received BTZ (0.2 mg/kg thrice weekly) for 4 wee...

  • Systematic Review
  • Open Access
36 Citations
6,729 Views
19 Pages

Patient-Reported Financial Distress in Cancer: A Systematic Review of Risk Factors in Universal Healthcare Systems

  • Sophie Pauge,
  • Bastian Surmann,
  • Katja Mehlis,
  • Andrea Zueger,
  • Luise Richter,
  • Natalja Menold,
  • Wolfgang Greiner and
  • Eva C. Winkler

7 October 2021

Financial toxicity is a side effect of cancer that results from the perceived financial distress an individual may experience in the course of the disease. The purpose of this paper is to analyse underlying factors related to subjective financial dis...

  • Article
  • Open Access
11 Citations
3,906 Views
12 Pages

Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome

  • Nils Welter,
  • Angelo Wagner,
  • Rhoikos Furtwängler,
  • Patrick Melchior,
  • Leo Kager,
  • Christian Vokuhl,
  • Jens-Peter Schenk,
  • Clemens Magnus Meier,
  • Stefan Siemer and
  • Manfred Gessler
  • + 1 author

7 October 2021

(1) Background: about 10% of Wilms Tumor (WT) patients have a malformation or cancer predisposition syndrome (CPS) with causative germline genetic or epigenetic variants. Knowledge on CPS is essential for genetic counselling. (2) Methods: this retros...

  • Systematic Review
  • Open Access
10 Citations
3,531 Views
13 Pages

Survival in Advanced-Stage Epithelial Ovarian Cancer Patients with Cardiophrenic Lymphadenopathy Who Underwent Cytoreductive Surgery: A Systematic Review and Meta-Analysis

  • Malika Kengsakul,
  • Gatske M. Nieuwenhuyzen-de Boer,
  • Anna H. J. Bijleveld,
  • Suwasin Udomkarnjananun,
  • Stephen J. Kerr,
  • Christa D. Niehot and
  • Heleen J. van Beekhuizen

7 October 2021

Purpose: To evaluate the clinical outcomes of enlarged cardiophrenic lymph node (CPLN) in advanced-stage epithelial ovarian cancer (AEOC) patients who underwent cytoreductive surgery. Methods: The Embase, Medline, Web of Science, Cochrane Library, an...

  • Article
  • Open Access
63 Citations
3,886 Views
14 Pages

Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index

  • Lukas Müller,
  • Felix Hahn,
  • Aline Mähringer-Kunz,
  • Fabian Stoehr,
  • Simon Johannes Gairing,
  • Maurice Michel,
  • Friedrich Foerster,
  • Arndt Weinmann,
  • Peter Robert Galle and
  • Jens Mittler
  • + 4 authors

7 October 2021

The novel CRP–albumin–lymphocyte (CALLY) index is an improved immunonutritive scoring system, based on serum C-reactive protein (CRP), serum albumin, and the lymphocyte count. It has shown promise as a prognostic index for patients with hepatocellula...

  • Article
  • Open Access
21 Citations
5,972 Views
22 Pages

Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity

  • Albin Jeanne,
  • Thomas Sarazin,
  • Magalie Charlé,
  • Catherine Moali,
  • Caroline Fichel,
  • Camille Boulagnon-Rombi,
  • Maïté Callewaert,
  • Marie-Christine Andry,
  • Eric Diesis and
  • Frédéric Delolme
  • + 2 authors

7 October 2021

TAX2 peptide is a cyclic peptide that acts as an orthosteric antagonist for thrombospondin-1 (TSP-1) interaction with CD47. TAX2 was first described for its anti-angiogenic activities and showed anti-cancer efficacy in numerous preclinical models. He...

  • Article
  • Open Access
17 Citations
4,722 Views
18 Pages

TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p

  • Girijesh Kumar Patel,
  • Sayanika Dutta,
  • Mosharaf Mahmud Syed,
  • Sabarish Ramachandran,
  • Monica Sharma,
  • Venkatesh Rajamanickam,
  • Vadivel Ganapathy,
  • David J. DeGraff,
  • Kevin Pruitt and
  • Manisha Tripathi
  • + 1 author

7 October 2021

Deciphering the mechanisms that drive transdifferentiation to neuroendocrine prostate cancer (NEPC) is crucial to identifying novel therapeutic strategies against this lethal and aggressive subtype of advanced prostate cancer (PCa). Further, the role...

  • Article
  • Open Access
17 Citations
4,311 Views
14 Pages

ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming

  • Dechen Wangmo,
  • Prem K. Premsrirut,
  • Ce Yuan,
  • William S. Morris,
  • Xianda Zhao and
  • Subbaya Subramanian

7 October 2021

Colorectal cancer (CRC) is one of the most common malignancies in both morbidity and mortality. Immune checkpoint blockade (ICB) treatments have been successful in a portion of mismatch repair-deficient (dMMR) CRC patients but have failed in mismatch...

of 30

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694